Validity of the diagnostic criteria for Parkinson's disease - Authors' reply

Affiliations

¹ The Edmond J Safra Program in Parkinson's Disease, Toronto Western Hospital, University of Toronto, Toronto, ON, Canada.
² Population Health Sciences, Bristol Medical School, University of Bristol, Bristol BS8 2PS, UK. Electronic address: y.ben-shlomo@bristol.ac.uk.
³ Centre of Expertise for Parkinson and Movement Disorders, Department of Neurology, Radboud University Medical Centre, Donders Institute for Brain, Cognition, and Behaviour, Nijmegen, Netherlands.
⁴ Washington University School of Medicine in St Louis, St Louis, MO, USA.
⁵ Weill Institute for Neurosciences, University of California San Francisco, San Francisco, CA, USA.

Comment

Connie Marras et al. Lancet. 2024.

. 2024 Aug 17;404(10453):652-653.

doi: 10.1016/S0140-6736(24)01363-1.

¹ The Edmond J Safra Program in Parkinson's Disease, Toronto Western Hospital, University of Toronto, Toronto, ON, Canada.
² Population Health Sciences, Bristol Medical School, University of Bristol, Bristol BS8 2PS, UK. Electronic address: y.ben-shlomo@bristol.ac.uk.
³ Centre of Expertise for Parkinson and Movement Disorders, Department of Neurology, Radboud University Medical Centre, Donders Institute for Brain, Cognition, and Behaviour, Nijmegen, Netherlands.
⁴ Washington University School of Medicine in St Louis, St Louis, MO, USA.
⁵ Weill Institute for Neurosciences, University of California San Francisco, San Francisco, CA, USA.

No abstract available

Comment on

Validity of the diagnostic criteria for Parkinson's disease.
He Y, Wang JG, Gao CQ. He Y, et al. Lancet. 2024 Aug 17;404(10453):652. doi: 10.1016/S0140-6736(24)01364-3. Lancet. 2024. PMID: 39153806 No abstract available.